Top Suppliers:I want be here
Related CAS#:
657-24-9 121369-64-0
1384526-74-2 1115-70-4
111101-13-4 851069-42-6
34461-22-8 737811-27-7
338752-31-1 506-59-2
1210597-70-8 1212315-81-5
1185328-79-3 1212688-42-0
1435995-26-8 2324093-42-5
1281035-76-4 1462991-68-9
2094931-57-2 1049573-61-6

657-24-9

657-24-9 structure
657-24-9 structure
  • Name: Metformin
  • Chemical Name: metformin
  • CAS Number: 657-24-9
  • Molecular Formula: C4H11N5
  • Molecular Weight: 129.164
  • Catalog: API Hormone and endocrine-regulating drugs Pancreatic hormones and other blood sugar regulating drugs
  • Create Date: 2018-09-23 09:48:56
  • Modify Date: 2025-08-20 22:58:03
  • Metformin (1,1-Dimethylbiguanide) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research. Metformin can cross the blood-brain barrier and triggers autophagy[1].
Name metformin
Synonyms Fluamine
N'-dimethylguanylguanidine
N,N-dimethylimidodicarbonimidic diamide
Diabex
N,N-dimethyl-biguanide
N,N-dimethylbiguanidine
1,1-Dimethylbiguanide
Metiguanide
Metforminum
Glumetza
Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
EINECS 211-517-8
Diabetosan
Glucophage
Description Metformin (1,1-Dimethylbiguanide) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research. Metformin can cross the blood-brain barrier and triggers autophagy[1].
Related Catalog
Target

AMPK

In Vitro Metformin (1,1-Dimethylbiguanide) inhibits proliferation of ESCs in a concentration-dependent manner. The IC50 is 2.45 mM for A-ESCs and 7.87 mM for N-ESCs. Metformin shows pronounced effects on activation of AMPK signaling in A-ESCs from secretory phase than in cells from proliferative phase[3]. Metformin (0-500 μM) decreases glycogen synthesis in a dose-dependent manner with an IC50 value of 196.5 μM in cultured rat hepatocytes[4]. Metformin shows cell viability and cytotoxic effects on PC-3 cells with IC50 of 5 mM[5].
In Vivo Metformin (1,1-Dimethylbiguanide; 100 mg/kg, p.o.) alone, and metformin (25, 50, 100 mg/kg) with isoproterenol groups attenuates myocyte necrosis through histopathological analysis[1]. Metformin (> 900 mg/kg/day, p.o.) results in moribundity/mortality and clinical signs of toxicity in Crl:CD(SD) rats[2].
References

[1]. Soraya H, et al. Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Pharmacol Rep. 2012;64(6):1476-84.

[2]. Quaile MP, et al. Toxicity and toxicokinetics of metformin in rats. Toxicol Appl Pharmacol. 2010 Mar 15;243(3):340-7.

[3]. Xue J, et al. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction. 2013 Aug 21;146(4):397-406.

[4]. Otto M, et al. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes Obes Metab. 2003 May;5(3):189-94.

[5]. Avci CB, et al. Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells. Asian Pac J Cancer Prev. 2013;14(2):765-8.
Density 1.0743
Boiling Point 229.23°C
Melting Point 199-200 °C
Molecular Formula C4H11N5
Molecular Weight 129.164
Flash Point 58.1±22.6 °C
Exact Mass 129.101440
PSA 88.99000
LogP -2.31
Appearance Solid,White to Light Brown
Vapour Pressure 1.3±0.3 mmHg at 25°C
Index of Refraction 1.576
Water Solubility Acetonitrile (Slightly), Aqueous Acid (Slightly), Dichloromethane (Slightly), DM

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DU1790000
CHEMICAL NAME :
Biguanide, 1,1-dimethyl-
CAS REGISTRY NUMBER :
657-24-9
LAST UPDATED :
199601
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C4-H11-N5
MOLECULAR WEIGHT :
129.20
WISWESSER LINE NOTATION :
MUYZMYUM&N1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
230 mg/kg
TOXIC EFFECTS :
Behavioral - hallucinations, distorted perceptions Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
247 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
146 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Parenteral
SPECIES OBSERVED :
Amphibian - frog
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Behavioral - hallucinations, distorted perceptions Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
6 gm/kg
SEX/DURATION :
female 1-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death

MUTATION DATA

TYPE OF TEST :
Cytogenetic analysis
TEST SYSTEM :
Rodent - hamster Lung
DOSE/DURATION :
2 gm/L/48H
REFERENCE :
GMCRDC Gann Monograph on Cancer Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No. 11- 1971- Volume(issue)/page/year: 27,95,1981 *** REVIEWS *** TOXICOLOGY REVIEW CLPTAT Clinical Pharmacology and Therapeutics (St. Louis). (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1960- Volume(issue)/page/year: 5,480,1964 TOXICOLOGY REVIEW ADVPA3 Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. Volume(issue)/page/year: 4,263,1966
1115-70-4 structure

1115-70-4

~10%

657-24-9 structure

657-24-9

Literature: Veisi, Hojat; Khazaei, Ardeshir; Safaei, Maryam; Kordestani, Davood Journal of Molecular Catalysis A: Chemical, 2014 , vol. 382, p. 106 - 113
1378856-94-0 structure

1378856-94-0

~%

657-24-9 structure

657-24-9

Literature: Journal of Molecular Structure, , vol. 996, # 1-3 p. 38 - 41
1170667-82-9 structure

1170667-82-9

~%

657-24-9 structure

657-24-9

Literature: WO2010/100337 A1, ; Page/Page column 9 ;
1170667-83-0 structure

1170667-83-0

~%

657-24-9 structure

657-24-9

Literature: WO2010/100337 A1, ; Page/Page column 9-10 ;
127099-85-8 structure

127099-85-8

~%

657-24-9 structure

657-24-9

Literature: Journal of the Chemical Society, , p. 1252,1255
506-59-2 structure

506-59-2

127099-85-8 structure

127099-85-8

~%

657-24-9 structure

657-24-9

Literature: Chemische Berichte, , vol. 62, p. 1394 Journal of the Chemical Society, , vol. 121, p. 1793
124-40-3 structure

124-40-3

127099-85-8 structure

127099-85-8

~%

657-24-9 structure

657-24-9

Literature: Chemische Berichte, , vol. 62, p. 1394 Journal of the Chemical Society, , vol. 121, p. 1793
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:657-24-9 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 657-24-9 | Chemsrc address: https://www.chemsrc.com/en/baike/889579.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved